TruCheck Cancer screening blood tests
Lisle Medical is delighted to partner with Datar Cancer Genetics (DCG) in offering the Trucheck range of cancer screening blood tests.
Across Europe every year 4.4 million new cancers are detected and there are 2 million cancer-related deaths. We know that cancers detected early are much more treatable, but sadly all too often cancers are detected at more advanced stages.
For years the search has been on for a reliable and accurate screening test for cancer. For a screening test to be acceptable it has to be cost-efficient, relatively straightforward for you, and most of all proven. We have known for some time that tumour cells circulate in the blood, and therefore the idea of identifying cancers from blood tests was seen as a potential gold standard target but was not feasible for years. Technology has now been proven (validated on more than 40,000 individuals) that isolates cancer cells from blood samples. We also know enough about what different cells look like to be able to identify from their unique fingerprint which part of the body they have come from. This is now revealing cancer in some cases at stages before they are visible on scans and current screening techniques.
The results of tests on these technologies have been so good that they have been given special status for early clearance as a ground-breaking technology in the US. 92.1% sensitivity at detecting all cancers, and 93.1% accuracy in determining the source of the tumour are excellent levels of success. This is irrespective of the extent of the disease, so early-stage cancers are reliably detected.
Trucheck tests are now available through Lisle Medical in partnership with DCG. We are even more delighted to offer this technology because the UK lab is truly local - DCG are based in Guildford!
Trucheck Intelli test requires just two blood tubes
There are different panels of tests:
Trucheck breast
Trucheck FemmeSafe (breast, ovary, endometrium, cervix)
Trucheck Prostate
Trucheck Colorectal/stomach
Trucheck diabetes (bladder, bowel, gallbladder, kidney, liver, pancreas - diabetics are twice as likely to develop some of these)
Trucheck intelli (up to 70 different tumours accounting for 81% of all cancer-related deaths)
If you would like to know more about the Trucheck Intelli test, please contact Lisle Medical and we can talk through the options and process. At Lisle Medical we want as many people as possible to access these tests and are offering the tests at retail price without additional margins. Please bear in mind these tests are not yet considered to be an alternative to existing screening programmes and you should continue to attend all appointments for cancer screening.
